PROGNOSIS, AND RISK ASSESSMENT, FOR CEREBRAL APOPLEXY PATIENTS BY DETERMINING MARKER PEPTIDE LEVEL

摘要

PROBLEM TO BE SOLVED: To provide an improved method for foreseeing outcome or assessing risks of a patient suffering from cerebral apoplexy or transient ischemic attack, the method including determination of the level of at least one marker peptide in samples from the patient.SOLUTION: By a method for foreseeing outcome or assessing risks of a patient suffering from cerebral apoplexy or transient ischemic attack, the level of at least one marker peptide in samples from the patient is determined, where the marker peptide is chosen from a group including ANP, AVP, ADM, ET-1, troponin, CRP, calcitonin and hGH, or a fragment thereof, or a precursor of any of the foregoing or a fragment thereof; and foreseeing the outcome or assessing the risks of the patient is attributable to the level of at least one of the marker peptides, its precursor or fragments.SELECTED DRAWING: Figure 1